CCL13 and myeloid sarcoma: In MS, upregulation of CCL13 levels in the brain tissue and cerebrospinal fluid can induce monocyte chemotaxis and the secretion of inflammatory cytokines in lymphocytes, ultimately, causing oligodendrocyte activation and myelin destruction (20, 104).